Patent · US Active

Modified viral strains and method for improving the production of vaccine seeds of influenza virus

US8956626B2 · kind B2 · utility

1Cited by

3References

14Claims

0Family size

Assignees

UNIVERSITE CLAUDE BERNAD LYON 1 · FR
HOSPICES CIVILS DE LYON · FR
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE · FR

Inventors

Vincent Moules · Belleville, FR
Manuel Rosa-Calatrava · Val-de-Reuil, FR
Olivier Ferraris · Bron, FR
Matthieu Yver · Val-de-Reuil, FR

Key dates

Filing date	Jul 8, 2011
Grant date	Feb 17, 2015
Priority date	—
Expiry date	Jul 8, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/16151
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Modified influenza A/PR/8/34 virus and reassortant influenza A/PR/8/34 virus including a modified PB1 gene and methods for improving the production of HA (hemagglutinin) and NA (neuraminidase) vaccine glycoproteins.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.